Related by context. All words. (Click for frequent words.) 79 subgroups 63 subpopulation 62 Subgroups 61 subset 57 subpopulations 56 prospectively defined 56 economically disadvantaged subgroup 55 socioeconomically disadvantaged 55 AYP benchmarks 55 economically disadvantaged subgroups 54 Economically disadvantaged students 54 demographic subgroups 54 subsets 54 tertile 53 socio economically disadvantaged 53 AYP 52 cohort 52 subtests 52 mITT 51 prespecified 51 coronary stenosis 51 subgroup analyzes 51 HbA 1c 51 statistically significant 50 reach statistical significance 50 multivariate analyzes 50 economically disadvantaged 50 histologic subtype 50 liver transplant recipients 50 IPAH 50 histological subtype 49 baseline HbA1c 49 HORNBACH Baumarkt AG 49 Average Yearly Progress 49 BMI z 49 retrospective cohort 49 bivariate analyzes 49 MMSE score 49 nonsignificant 49 attain statistical significance 49 nonobese 49 Subgroup analyzes 49 EDNOS 49 Economically Disadvantaged 48 completely resected 48 NIH CPSI 48 MMSE scores 48 tertiles 48 DAS# scores 48 statistical significance 48 osteopenic 48 schizophreniform disorder 48 EDSS score 48 subcategory 48 baseline LDH 48 antibody titer 48 Subgroup 48 squamous histology 48 systolic dysfunction 48 NYHA functional class 48 K ras mutation 48 docetaxel pretreated 48 System IPSS 48 GHSGT 48 familial clustering 48 TT genotype 48 Hb A1C 48 PSAE 47 MADRS score 47 elevated LDH 47 univariate 47 DSM IV diagnosis 47 noninferiority 47 highest quintile 47 SORT OUT III 47 subanalysis 47 LVEF 47 anemia hemoglobin 47 sagittal abdominal diameter 47 hydroxyvitamin D levels 47 T2DM 47 lowest tertile 47 habitual snoring 47 non squamous histology 47 univariate analysis 47 CC genotype 47 Multivariate analysis 47 Brief Psychiatric 47 metabolically healthy 47 Montgomery Åsberg Depression 47 subsyndromal 47 TEAEs 47 Annual Yearly Progress 47 covariate 47 dosing cohort 47 Univariate analysis 47 syndromal 47 prostate cancer CaP 47 glycated hemoglobin 47 multivariable analysis 47 adverse cytogenetics 47 polyp recurrence 47 univariate analyzes 47 normotensive 47 virologic failure 47 socioeconomically disadvantaged students 47 serum selenium 47 allele frequencies 47 interobserver reliability 47 MADIT CRT trial 47 efficacy endpoint 47 Academic Yearly Progress 47 mITT population 46 histologically confirmed 46 clinicopathological 46 nmol L 46 amnestic MCI 46 apnea hypopnea index 46 sociodemographic 46 unpaired t 46 SNP rs# [002] 46 serum creatinine levels 46 SIMPADICO 46 post hoc 46 subclinical atherosclerosis 46 lowest quintile 46 HNSCC 46 periprocedural MI 46 microbiologically evaluable 46 subclinical hypothyroidism 46 NYHA Class II 46 liver histology 46 nonresponders 46 eplerenone 46 Adequate Yearly Progress AYP 46 HER2 expression 46 math proficiency 46 logistic regression analysis 46 cTnT levels 46 confounding variables 46 Adequate Yearly Progress 46 hepatitis C genotype 46 proband 46 seronegative 46 HIV HCV coinfected 46 ALT elevations 46 substudy 46 anti JCV antibodies 46 rheumatoid factor 46 subscales 46 HbA 1c levels 46 NHANES III 46 Ashworth Scale 46 HIV uninfected 46 symptomatic intracerebral hemorrhage 46 HbA1C levels 46 comorbidities 46 plasma selenium 46 poor metabolizers 46 efficacy evaluable 46 HAM D 46 serum triglyceride 46 non inferiority 46 highest tertile 46 HOMA IR 46 HbA1C 46 serum vitamin D 46 genetic polymorphisms 46 statistically nonsignificant 46 fasting glucose 45 VADT 45 prognostic variables 45 carotid plaque 45 statistical significance p 45 Y BOCS 45 CTEPH 45 statistically significant p = 45 impaired fasting glucose 45 logistic regression model 45 tumor histology 45 NNRTI resistance 45 suicide attempters 45 hypertensives 45 AYP Adequate Yearly Progress 45 stratifying patients 45 ADHD RS 45 mcg albinterferon alfa 2b 45 leukopenia 45 molecularly defined 45 achieved statistical significance 45 GH deficiency 45 DAS# CRP 45 advanced adenomas 45 homocysteine concentrations 45 definite stent thrombosis 45 lipid lowering medications 45 multivariate adjustment 45 Kaplan Meier analysis 45 SDAA II 45 dihydropyridine 45 statistically significant differences 45 NCEP ATP III 45 narcolepsy cataplexy 45 neurocognitive functioning 45 perioperative complications 45 histologically proven 45 evaluable 45 hematopoietic cancers 45 adequate yearly 45 virological response 45 atheroma volume 45 subtest 45 MGUS 45 nonsignificant difference 45 randomized trials 45 bivariate 45 hyperhomocysteinemia 45 nondepressed 45 p = .# [002] 45 socioeconomic status SES 45 serum calcium 45 sd = 45 psychiatric comorbidity 45 WOMAC scores 45 NYHA 45 hormone receptor negative 45 ECOG 45 prepubertal 45 EGFR mutations 45 locoregional recurrence 45 missense mutations 45 p = #.# [003] 45 fasting insulin 45 COMT genotype 45 alanine aminotransferase ALT 45 limiting generalizability 45 genotypic resistance 45 histologies 45 #.#ng/ml 45 LV dysfunction 45 posaconazole 45 Subgroup analysis 45 rs# [004] 45 interrater reliability 45 secondary efficacy endpoints 45 multivariate analysis 45 CR nPR 45 DLQI 45 subscores 45 undetectable HBV DNA 45 viremic 45 virologic response 45 decompensated liver disease 45 sociodemographic variables 45 antibody titers 45 hepatocellular carcinomas 45 multiple logistic regression 45 sustained virological response 45 histologic 45 deciles 45 μg dose 45 coinfected patients 45 EURIDIS 45 cirrhotic patients 45 hemoglobin A1c levels 45 Longitudinal studies 45 KRAS mutation 45 carotid plaques 45 salivary cotinine 45 math CRCT 44 coinfected 44 A1c levels 44 ANCOVA 44 hemoglobin concentration 44 prognostic factors 44 MetS 44 HLA A2 44 psychiatric comorbidities 44 serum concentrations 44 CIN3 44 ADAS Cog 44 secondary endpoint 44 primary endpoint 44 HGPIN 44 plasma folate 44 completers 44 nonexposed 44 axillary lymph node 44 advanced adenoma 44 BENICAR HCT 44 psychosocial functioning 44 clinicopathologic 44 clinically meaningful improvement 44 euthymic 44 subscale scores 44 pCR 44 intraobserver 44 hsCRP levels 44 URTI 44 mg BID dose 44 hippocampal volume 44 ischemic cardiomyopathy 44 probands 44 aged ≥ 44 albumin excretion rate 44 ethnically diverse populations 44 recurrent coronary 44 serous ovarian cancer 44 prevalences 44 #/#mmHg 44 protease inhibitor mutations 44 nondiabetic patients 44 cognitive domains 44 cognitively intact 44 ALLHAT 44 prophylactic cranial irradiation 44 nonrandomized 44 serum folate concentrations 44 nondemented 44 glucose intolerant 44 Caucasians 44 PREZISTA r arm 44 cranial irradiation 44 non affective psychosis 44 Commended Performance 44 baseline A1C 44 CORE OM 44 EQ 5D 44 pretest probability 44 diastolic blood pressures 44 isolated systolic hypertension 44 HSCT 44 coinfection 44 colorectal adenoma 44 visceral metastases 44 seroprotection 44 composite endpoint 44 heavily pretreated 44 Cognitive Abilities Test 44 achieved sustained virological 44 nonfatal MI 44 ertapenem 44 median PFS 44 serum markers 44 Confidence Interval 44 esophageal squamous cell carcinoma 44 serum IGF 44 preoperative PSA 44 obstructive coronary artery 44 elevated triglyceride levels 44 receiving golimumab 44 n = 44 DSM IV criteria 44 LDL particle 44 T2 lesions 44 latent tuberculosis infection 44 aminotransferases 44 chromosomal alterations 44 prospective cohort 44 EoE 44 adenoma recurrence 44 Kaplan Meier curves 44 TOP2A 44 AZ Learns 44 observational cohort study 44 abdominal adiposity 44 arterial thromboembolic events 44 census tracts 44 μmol L 44 subscore 44 premenopausal 44 HbA 1C 44 recurrent VTE 44 subtype 44 colorectal neoplasia 44 Baseline characteristics 44 SEER registry 44 neoplasias 44 serum ferritin 44 depressive symptoms 44 ANOVA 44 covariates 44 slow metabolizers 44 ECG abnormalities 44 diameter stenosis 44 gadobutrol 44 % CI #.#-#.# [007] 44 BMI percentiles 44 metformin monotherapy 44 MMSE 44 pT2 44 plasma pharmacokinetics 44 CsA 44 Bacteroides 44 receiving Vectibix monotherapy 44 ECOG PS 44 CAPRIE 44 socioeconomic status 44 nondiabetic 44 ascending doses 44 severe periodontitis 44 umol L 44 chromosome #q#.# [001] 44 A1Cs 44 Heritability 44 SNP rs# [001] 44 Crohn Disease Activity 44 ethnicity socioeconomic status 44 adiponectin concentrations 44 Multivariate analyzes 44 nonsmall cell lung cancer 44 nonadherent 44 Adequate yearly 44 CELDT 44 ICD therapy 44 KRAS mutations 44 elevated triglycerides 44 unfavorable cytogenetics 44 adenocarcinoma histology 44 nonvertebral fractures 43 leukocyte count 43 squamous 43 epithelioid 43 APOE genotype 43 biopsy Gleason 43 placebo 43 bladder carcinoma 43 sirolimus stent 43 multivariate Cox 43 macroalbuminuria 43 PCNSL 43 clinically evaluable 43 somatic symptoms 43 hemoglobin A1C 43 cryptogenic 43 creatinine levels 43 RESIST studies 43 LTBI 43 somatoform disorders 43 thromboembolic complications 43 OGTT 43 Charlson comorbidity index 43 undergoing coronary angiography 43 secondary efficacy endpoint 43 adjuvant chemotherapy 43 conjugated equine estrogen 43 INTERHEART 43 generalizability 43 troponin T 43 DAS# [002] 43 waist circumferences 43 EDSS scores 43 TIMI 43 quintiles 43 systolic blood pressures 43 Among 43 serum creatinine 43 hsCRP 43 HBeAg negative patients 43 ConclusionThis 43 splenectomized patients 43 NRTI 43 hip BMD 43 Bonferroni correction 43 placebo controlled studies 43 evaluable subjects 43 tirofiban 43 serum phosphate levels 43 CD# expression [002] 43 KDOQI 43 HBeAg positive 43 Non inferiority 43 ear effusion 43 nmol L. 43 Index CDAI 43 CARDIA 43 HAM D# 43 ASD prevalence 43 extensive metabolizers 43 atherothrombotic disease 43 Observational studies 43 randomized controlled trials 43 T1DM 43 HbA1c levels 43 adenoma 43 seropositivity 43 GH deficient 43 Symptom Checklist 43 confounders 43 gene polymorphism 43 NAbs 43 obscure gastrointestinal bleeding 43 Estrogen Receptor 43 transferrin saturation 43 Graduation Qualifying Exam 43 serum uric acid 43 elevated ALT 43 folate concentrations 43 SAEs 43 antithrombotic agents 43 sociodemographic factors 43 logistic regression analyzes 43 logistic regression models 43 stage IIIB 43 racial disparities persist 43 #q# deletion syndrome 43 strongest predictors 43 multivessel disease 43 morphometric vertebral fractures 43 antihypertensive agents 43 genotype 43 sUA 43 GSTM1 43 premorbid 43 recurrent UTI 43 Hp2 2 43 glycated hemoglobin HbA1c 43 BCG vaccinated 43 mg ustekinumab 43 prognostically 43 nonsevere 43 observational cohort 43 EGFR mutation positive 43 nonpregnant women 43 beta carotene supplementation 43 carotid IMT 43 mg dL 43 active comparator 43 quartiles 43 hemoglobin A1c HbA1c 43 Intervention Trial 43 FeNO 43 angiotensin converting enzyme inhibitors 43 eGFR 43 advanced neoplasia 43 DSMB 43 thyrotropin levels 43 ASCUS 43 posttest 43 apolipoprotein B 43 hyperoxaluria 43 HRQL 43 PNH patients 43 % CI #.#-#.# [008] 43 meta analytic 43 cystatin 43 BPRS 43 mmol l 43 #mg/dL [001] 43 aminotransferase 43 ERGs 43 abnormal cytology 43 psychiatric outpatients 43 immunoreactivity 43 MPCP 43 racially imbalanced 43 TRITON TIMI 43 STRIDE PD 43 serum retinol 43 Socioeconomic status 43 infarcts 43 NSTE ACS 43 T1a 43 ± SEM 43 carotid artery narrowing 43 YMRS 43 urate levels 43 de novo AML 43 coronary calcification 43 pharmacodynamic parameters 43 thyroglobulin 43 Dulcan 43 randomized controlled trials RCTs 43 S. maltophilia 43 meta analysis 43 residual platelet reactivity 43 prognostic biomarker 43 colorectal polyp 43 HBeAg negative 43 psychosocial variables 43 phenotypic characteristics 43 fructose intolerance 43 distinct subtypes 43 lymph node metastases 43 FLT3 mutations 43 elevated troponin 43 albumin excretion 43 binary restenosis 43 socioeconomic variables 43 Maori Pasifika 43 GSTM1 gene 43 genotype 1a 43 #mg/day [001] 43 CYP#C# genotype 43 correlation coefficients 43 HMGA1 43 CVD mortality 43 IgA deficiency 43 baseline CD4 43 C1q 43 undergoing CABG 43 subclinical hyperthyroidism 43 MELD scores 43 telomere lengths 43 Depression Inventory 43 VaD 43 resected pancreatic cancer 43 Cooperative Oncology 43 clazosentan 43 randomized placebo controlled 43 ovarian carcinoma 43 NSTEMI 43 clinically meaningful 43 mg dose 43 cTnT 43 International Prognostic Scoring 43 Fibromyalgia Impact Questionnaire 43 squamous cell histology 43 external genital lesions 43 carotid stenosis 43 relapsed SCLC 43 HCCs 43 atopic 43 Thrombolysis 43 biochemical recurrence 43 underwent CABG 43 HRQoL 42 pT3 42 lymph node involvement 42 vicriviroc 42 small lymphocytic lymphoma 42 dysglycemia 42 SGAs 42 Onrigin 42 acute exacerbation 42 mg kg Hematide 42 fragility fracture 42 caspofungin 42 heterozygotes 42 socioeconomic gradient 42 metastatic lymph nodes 42 hypogonadal 42 criterion referenced 42 GQE 42 Prehypertension 42 clinico pathological 42 REYATAZ r arm 42 nodal metastases 42 subtypes 42 baseline serum bilirubin 42 UA NSTEMI 42 biochemical relapse 42 elevated CRP 42 nutrient intakes 42 % CI #.#-#.# [004] 42 Rating Scale BPRS 42 breast cancer subtypes 42 Hornbach Baumarkt AG 42 hematologic toxicity 42 CCyR 42 laboratory abnormalities 42 prospectively enrolled 42 serum parathyroid hormone 42 abnormal lipids 42 YPDP 42 aminotransferase levels 42 Swedish Mammography Cohort 42 K ras mutations 42 MACCE 42 NAFLD 42 serum PSA 42 antihypertensive medications 42 postoperative complication 42 indolent lymphomas 42 onset atrial fibrillation 42 Her2/neu 42 primary efficacy endpoint 42 LS BMD 42 HbA1c 42 prospectively randomized 42 WOMAC pain 42 Meta analyzes 42 comorbid disorders 42 somatic symptom 42 lymphocyte counts 42 airway responsiveness 42 ≥ 42 predictive validity 42 randomized 42 nonfasting triglyceride levels 42 intima media thickness IMT 42 leucopenia 42 HDL cholesterol triglycerides 42 thromboembolic events 42 Stage IIIb 42 symptomatic VTE 42 longitudinal observational study 42 proteinuria 42 thiopurine 42 abstainers 42 noncardiac 42 subsample 42 ruboxistaurin 42 Hamilton Rating Scale 42 nonfasting triglycerides 42 ACR# ACR# 42 elevated IOP 42 ABCB1 42 placebo controlled trials 42 FDA defined valvulopathy 42 CANCIDAS 42 epithelial ovarian cancer 42 initiating antiretroviral therapy 42 serum phosphorous 42 antiphospholipid antibodies 42 FOLPI 42 neoplasm 42 GCSE attainment 42 DAS# remission 42 serum lipid levels 42 HBeAg 42 prevalent vertebral fracture 42 OPRM1 42 neurodevelopmental impairment 42 estimated GFR 42 residual confounding 42 ATTAIN 42 immunocompetent 42 microdeletion 42 pharmacokinetics PK 42 prospective randomized multicenter 42 vertebral fracture 42 metaanalysis 42 LV systolic dysfunction 42 shorter telomere length 42 MRSA isolates 42 Multi Ethnic Study 42 eNO 42 euthymic patients 42 confounder 42 HGD 42 estimated glomerular filtration 42 APOE e4 42 ELBW infants 42 relapsed AML 42 thyroid nodules 42 serologic 42 lignan intake 42 follicular adenoma 42 cTnI 42 CIMZIA TM certolizumab pegol 42 HBsAg 42 Economically disadvantaged 42 affective psychosis 42 atopy 42 triglyceride concentrations 42 cognitively normal 42 PCa 42 hs CRP 42 specific antigen PSA 42 Viral load 42 UPDRS motor 42 elevated hsCRP 42 Montgomery Asberg Depression 42 oral Hycamtin 42 virological failure 42 group 42 mutated K ras 42 causative mutation 42 colesevelam 42 Asymptomatic 42 null responder 42 Hb levels 42 SSRI citalopram 42 lifetime abstainers 42 #q#.# deletion syndrome 42 serum testosterone 42 statistically significant p 42 intravesical therapy 42 nadroparin 42 hypercoagulable 42 follicular lymphoma FL 42 ACUITY trial 42 GRK5 42 hepatocellular carcinoma HCC 42 #ng/ml 42 unfavorable prognostic 42 hippocampal volumes 42 CSAP scores 42 GIK infusion 42 PsA 42 prospective randomized controlled 42 adenomatous polyps 42 DLTs 42 serum potassium 42 antigen PSA levels 42 interindividual variability 42 carotid bruit 42 RCTs 42 HBeAg negative chronic hepatitis 42 chi ^ sup 42 non squamous NSCLC 42 prognostic significance 42 variant allele 42 null responder HCV 42 subsamples 42 prehypertensive 42 College Readiness Benchmarks 42 glycated hemoglobin levels 42 transaminase elevations 42 plasma leptin 42 lymphoproliferative disorders 42 IIIA NSCLC 42 underwent resection 42 Psoriasis Area 42 ISAT scores 42 SCr 42 urodynamic parameters 42 dopamine transporter gene 42 cardiovascular mortality 42 antiretroviral naïve 42 census tract 42 overnight polysomnography 42 serum urate levels 42 chlamydial infection 42 complete cytogenetic response 42 vismodegib 42 CALGB 42 MADIT CRT 42 spirometric 42 retrospective cohort study 42 tHcy 42 teriflunomide 42 neurocognitive function 42 neutrophil counts 42 statistically significant reduction 42 mCRC patients 42 prospective multicentre 42 Liraglutide Effect 42 chronicity 42 etiologic 42 language learners 42 ejection fractions 42 comorbidity 42 CYPHER Stent 42 odds ratios ORs 42 primary endpoints 42 chronic urticaria 42 diuretic chlorthalidone 42 Virologic failure 42 Medication adherence 42 APTIVUS r 42 adjuvant therapy 42 baseline FEV 42 fasting serum 42 prognostic factor 42 molecular subtypes 42 Complication rates 42 atherogenic dyslipidemia 42 sustained virologic response 42 RLS sufferers 42 nonmetastatic 42 Primary endpoints 42 Asian Pacific Islander 42 serogroup 42 microscopic hematuria 42 rs# [003] 42 Avandia Actos 42 serum triglycerides 42 glycosylated hemoglobin 42 lamotrigine 42 waist girth 42 alcohol dehydrogenase ADH 42 etiologic factors 42 somatoform disorder 42 intima media thickness 42 NHANES surveys 42 randomized multicenter 42 malignant polyps 42 BMI percentile 42 stage IIIb IV 42 Depressive symptoms 42 chlorthalidone 42 % CI #.#-#.# [003] 42 LEXIVA r 42 Kinoid 42 mg/m2 dose 42 serum folate 42 intelligence quotient IQ 42 ALT flares 42 fetuin 42 posttreatment 42 NIHSS 42 grade cervical intraepithelial 42 seroprevalence 42 predefined criteria 42 serum cholesterol 42 ADAS cog 42 Schaffir 42 CHADS 42 mg Proellex 42 warfarin dose 42 Prostate Lung Colorectal 42 SAT takers 42 nontasters 42 lung adenocarcinomas 42 nucleoside naive 42 Cognitive impairment 42 genotypic 42 abacavir Ziagen 42 longitudinal studies 42 #mmHg [001] 42 fructose intolerant 42 mg kg dose 42 serum BDNF 42 fructosamine 42 prostate cancer PCa 42 MGd 42 nasal polyposis 41 CLBP 41 dyads 41 hypertensive patients 41 glomerular filtration 41 lipid elevations 41 dose dose escalation 41 histopathologic 41 null responders 41 NYHA class 41 P = .# 41 CYP#D# genotype 41 hereditary predisposition 41 histological subtypes 41 Eleventh graders 41 chronic periodontitis 41 prognostic indicators 41 lumbar spine BMD 41 ACCORD Lipid 41 neovascular glaucoma 41 g dL 41 supratentorial 41 estrogen receptor negative 41 TNF antagonist 41 susceptibility loci 41 KRAS status 41 multivariable Cox 41 Advanced Proficient 41 omalizumab 41 arterial thickening 41 β blockers 41 Districtwide 41 baseline serum creatinine 41 prospective longitudinal 41 H. pylori eradication 41 colorectal adenomas 41 PERMP 41 FluCAM arm 41 μg L 41 lymphoproliferative 41 postoperative radiotherapy 41 Hispanic whites 41 p# biomarker 41 serum lipids 41 reactogenicity 41 multivariate regression analysis 41 fractional anisotropy 41 ELA exam 41 p = #.# [002] 41 coronary artery calcium 41 hypercalciuria 41 kidney allograft 41 conditional logistic regression 41 % CI #.#-#.# [006] 41 micrometastases 41 #p# [001] 41 abatacept 41 HPV subtypes 41 nonoperative 41 paricalcitol 41 epithelial tumors 41 hypoglycemic episodes 41 #OHD levels 41 methotrexate therapy 41 pilocytic astrocytomas 41 HYVET 41 autonomic dysfunction 41 PUFA intake 41 ELLs 41 Timed Walk 41 ceftriaxone 41 CTCAE 41 density lipoprotein cholesterol 41 multivariable adjusted 41 Excessive daytime sleepiness 41 bronchial hyperresponsiveness 41 haplogroups 41 prospectively stratified 41 extrapyramidal symptoms 41 femoral neck fracture 41 HMG CoA reductase inhibitor